Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  West Pharmaceutical Services Inc.    WST

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales1 3681 4211 4001 5151 6311 762
Operating income (EBITDA)248273280318365413
Operating profit (EBIT)162183190220264306
Pre-Tax Profit (EBT)------
Net income11212795,6155196231
P/E ratio31,230,446,344,032,527,2
EPS ( $ )1,571,751,301,922,593,10
Dividend per Share ( $ )0,390,410,460,490,530,58
Yield0,79%0,77%0,76%0,58%0,63%0,69%
Reference price ( $ )49.0653.2460.2284.2184.2184.21
Announcement Date02/20/2014
12:00pm
02/19/2015
12:00pm
02/18/2016
12:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt---36,03,406,70
Finance------
Operating income (EBITDA)248273280318365413
Leverage
(Debt/EBITDA)
---0,11x0,01x0,02x
Capital Expenditure--132160155155
Book Value Per Share (BVPS)--14,2 $15,7 $17,2 $18,9 $
Cash Flow per Share3,09 $2,51 $2,88 $2,98 $3,88 $4,42 $
Announcement Date02/20/2014
12:00pm
02/19/2015
12:00pm
02/18/2016
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 6 163 M$ -
Entreprise Value (EV) 6 199 M$ 6 166 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 44,0x 32,5x
Capitalization / Revenue 4,07x 3,78x
EV / Revenue 4,09x 3,78x
EV / EBITDA 19,5x 16,9x
Yield (DPS / Price) 0,58% 0,63%
Price to book (Price / BVPS) 5,37x 4,89x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 14,5% 16,2%
operating Leverage (Delta EBIT / Delta Sales) 1,91x 2,65x
Net Margin (Net Profit / Revenue) 10,3% 12,0%
ROA (Net Profit / Asset) 8,30% 10,6%
ROE (Net Profit / Equities) 14,0% 15,7%
Rate of Dividend 25,6% 20,4%
Balance Sheet Analysis 2016e 2017e
CAPEX / CA   10,6% 9,50%
Cash Flow / Sales 14,4% 17,4%
Capital Intensity (Assets / Sales) 1,24x 1,13x
Financial Leverage (Net Debt / EBITDA) 0,11x 0,01x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend